- Associated Press•3 days ago
The Migdal Ha Emeq, Israel-based company said it had a loss of 18 cents per share. Losses, adjusted for non-recurring costs and stock option expense, were 10 cents per share. The results fell short of ...
- GlobeNewswire•3 days ago
MIGDAL HA'EMEQ, Israel, Feb. 22, 2017-- Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today reported financial results for the fourth ...
- GlobeNewswire•19 days ago
$2.0 million inventory write-off impacts GAAP and non-GAAP EPS by. $0.9 million bad debt provision impacts GAAP EPS by. MIGDAL HA'EMEQ, Israel, Feb. 06, 2017-- Enzymotec Ltd., a developer, manufacturer ...
ENZY : Summary for Enzymotec Ltd. - Yahoo Finance
Enzymotec Ltd. (ENZY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Ask||9.20 x 100|
|Day's Range||9.10 - 9.15|
|52 Week Range||5.20 - 9.32|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||85.51|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|